News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Nanobiotix (NASDAQ:NBTX) had its price target raised by analysts at Guggenheim from $8.00 to $26.00. They now have a "buy" rating on the stock.

Nanobiotix (NASDAQ:NBTX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris [Yahoo! Finance]

Form 6-K Nanobiotix S.A. For: Dec 17

Form 6-K Nanobiotix S.A. For: Dec 15

Form 6-K Nanobiotix S.A. For: Dec 01

Form 6-K Nanobiotix S.A. For: Nov 24

Form 6-K Nanobiotix S.A. For: Nov 13

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}